logo

For the Inventor, By the Inventor

Taastrup, Denmark

Henrik Bengtsson

This inventor holds 42 USPTO granted patents and 32 published patent applications and 34 EPO patents, primarily in Drug Delivery Systems. Top assignees: Novo Nordisk A/s, Novo Nordick A/s, Other. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henrik Bengtsson. Retrieved from https://idiyas.com/inventor/henrik-bengtsson-avubpsd6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 42 

% Patents Active = 73.8

 

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 1,103(Granted Patents)


Location History:

  • Frederiksberg, DK (2006 - 2009)
  • Taastrup, DK (2011 - 2024)

Company Filing History:

goldMedal40 out of 1,804 
 
Novo Nordisk A/s
 patents
silverMedal1 out of 6 
 
Novo Nordick A/s
 patents
bronzeMedal1 out of 834,601 
Other
 patents

Years Active: 2006-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Drug Delivery System
Insulin Regimen
Bolus Timing
Adaptive Titration
Glucose Measurements
Injection Device
Needle Unit
Electronic Communication
Piston Washer
Hypoglycemic Risk
Medication Adherence
Multipolar Magnet
42 patents (USPTO):Explore Patents
1. 12478741 - Drug delivery system with multipolar magnet and sensor system (2025-11-25),
2. 12144968 - Flow communication unit with unconnected and connected configuration (2024-11-19),
3. 12109392 - Basal titration with adaptive target glucose level (2024-10-08),
4. 11944791 - Multi-use drug delivery device for drugs with less preservatives (2024-04-02),
5. 11684722 - Drug delivery system with multipolar magnet and sensor system (2023-06-27),
6. 11631486 - Systems and methods for optimization of bolus timing relative to meal events (2023-04-18),
7. 11562816 - Systems and methods for analysis of insulin regimen adherence data (2023-01-24),
8. 11521730 - Systems and methods for the determination of insulin sensitivity (2022-12-06),
9. 11491283 - Needle unit with floating needle hub (2022-11-08),
10. 11464447 - Regimen adherence measure for insulin treatment based on glucose measurements and insulin pen data (2022-10-11),
11. 11462313 - Systems and methods for adjusting a basal/bolus ratio in an insulin regimen (2022-10-04),
12. 11439756 - Flow communication unit with preservative (2022-09-13),
13. 11373759 - Systems and methods for estimating the risk of a future hypoglycemic event (2022-06-28),
14. 11373746 - Basal titration with adaptive target glucose level (2022-06-28),
15. 11298461 - Basal titration with adaptive target glucose level (2022-04-12),

Title: Henrik Bengtsson: Pioneering Innovations for a Better Tomorrow

Introduction: Henrik Bengtsson, a visionary inventor based in Taastrup, Denmark, is renowned for his unwavering commitment to pushing the boundaries of technological advancements. With 40 patents to his name, his inventive spirit and passion for creating solutions for the future continue to inspire others in the field.

Latest Patents: Henrik Bengtsson's latest patents showcase his ingenuity in the realm of healthcare technology. One of his notable innovations includes the "Basal Titration with Adaptive Target Glucose Level" system, which adjusts long-acting insulin dosages for individuals based on timestamped glucose measurements. Another remarkable patent is the "Multi-Use Drug Delivery Device for Drugs with Less Preservatives", designed to provide extended drug delivery with minimized risk of contamination.

Career Highlights: Henrik Bengtsson has made significant contributions to the industry through his work with esteemed companies like Novo Nordisk A/S. His dedication to excellence and drive for innovation have propelled him to the forefront of technological advancements in the healthcare sector.

Collaborations: Throughout his career, Henrik Bengtsson has collaborated with talented individuals such as Tinna Bjork Aradottir and Pete Brockmeier. Together, they have worked towards developing cutting-edge solutions that have the potential to revolutionize the field of medical technology.

Conclusion: Henrik Bengtsson's pioneering spirit and dedication to innovation make him a true trailblazer in the world of technology. His remarkable patents and collaborations serve as a testament to his visionary approach towards creating a better future through advancements in healthcare technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…